Determining Fetal Stomach Size and Associated Concerns
An obstetrician determines if a fetus has a small stomach through transabdominal ultrasound measurement of stomach dimensions (longitudinal, anteroposterior, and transverse diameters), comparing these measurements to gestational age-specific nomograms, with a small or absent stomach after 18 weeks gestation carrying a 52-85% risk of abnormal outcome including structural abnormalities, chromosomal anomalies, and fetal/neonatal death. 1, 2
How to Determine Small Fetal Stomach
Ultrasound Assessment Method
Transabdominal ultrasound is the primary imaging modality for evaluating fetal stomach size, performed as part of the detailed fetal anatomic examination. 3
Measure three stomach dimensions: longitudinal, anteroposterior, and transverse diameters using real-time high-resolution ultrasound. 2
Compare measurements to gestational age-specific nomograms: Normal fetal stomach shows linear growth throughout pregnancy with high correlation between gestational age and all three diameters (r = 0.749-0.809). 2
The stomach is considered abnormal if: the stomach bubble is absent or remains very small and unchanged for at least 45 minutes during sonographic examination after 14 weeks gestation. 4
Timing Considerations
Evaluate after 18 weeks gestation: A small or absent stomach before this time may be less clinically significant. 1
Serial examinations are critical: A single non-visualization may be transient, but repeat imaging should occur to confirm persistent findings. 4
Detailed anatomic survey should be performed at 18-22 weeks as part of routine screening, with the stomach being one of the required structures to visualize. 3
Clinical Concerns and Prognosis
Overall Outcomes
Absent stomach carries 85% risk of abnormal outcome including structural abnormalities, intrauterine fetal death, or postnatal death. 1
Small stomach carries 52% risk of abnormal outcome, significantly better than absent stomach but still concerning. 1
Combined risk is 63% when either finding is present after 18 weeks gestation. 1
Specific Associated Abnormalities
Chromosomal Anomalies:
- 38% of fetuses with absent stomach have abnormal karyotype. 1
- 4% of fetuses with small stomach have abnormal karyotype. 1
- Diagnostic testing with chromosomal microarray analysis should be offered when fetal growth restriction is detected with malformations or when unexplained isolated growth restriction is diagnosed before 32 weeks. 3
Structural Abnormalities:
- Gastrointestinal anomalies including esophageal atresia, tracheoesophageal fistula, duodenal atresia, and gastroschisis are common associations. 3, 1
- Central nervous system anomalies may coexist, requiring detailed neurologic assessment. 3
- Approximately 10% of fetuses with growth restriction have congenital anomalies. 3
Amniotic Fluid Abnormalities:
- 88% abnormal outcome when oligohydramnios is present with non-visualized stomach. 4
- 100% abnormal outcome when polyhydramnios is present with non-visualized stomach. 4
- Amniotic fluid volume assessment is critical in all cases of suspected stomach abnormalities. 3
Important Clinical Pitfalls
Transient Findings:
- Not all transient non-visualizations are benign: 25% of cases where the stomach normalized on subsequent scans still had abnormal outcomes including persistent postnatal disability. 4
- Serial imaging is mandatory even when initial follow-up shows normal stomach. 4
Isolated Findings:
- 48% of cases have non-visualization as the only abnormal finding, yet 20% of these still have abnormal outcomes. 1, 4
- Do not be falsely reassured by absence of other anomalies on initial scan. 4
Additional Abnormalities:
- 88% abnormal outcome when other sonographic abnormalities are present alongside stomach findings. 4
- Detailed anatomic survey is essential to identify associated malformations. 3
Management Algorithm
Initial Detection of Small/Absent Stomach
Confirm finding with extended observation (minimum 45 minutes) to exclude transient non-filling. 4
Perform detailed fetal anatomic examination (CPT 76811) to identify associated structural abnormalities. 3
Assess amniotic fluid volume as this significantly impacts prognosis. 3, 4
Evaluate for fetal growth restriction using estimated fetal weight and abdominal circumference measurements. 3
Diagnostic Workup
Offer genetic testing with chromosomal microarray analysis, especially if detected before 32 weeks or if other abnormalities are present. 3
Consider fetal MRI if ultrasound findings are incomplete or additional anatomic detail is needed, ideally performed at or after 22 weeks gestation. 3
Screen for cytomegalovirus via amniocentesis PCR in unexplained cases. 3